Medicare Enrolled
Dr. Afzal Rehman, MD, PHD.
Cardiovascular Disease · Johnson City, NY
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rehman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rehman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rehman
Dr. Afzal Rehman is a cardiovascular disease specialist in Johnson City, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rehman performed 3,106 Medicare services across 1,722 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rehman received a total of $10,136 from 48 pharmaceutical and/or device companies across 330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rehman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 30% volume in NY
$10,136 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,106
Medicare services
Top 30% in NY for cardiovascular disease
1,722
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~155 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
820 | $15 | $77 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
568 | $20 | $113 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
317 | $34 | $119 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
256 | $24 | $220 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
238 | $17 | $85 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
182 | $50 | $181 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $85 | $238 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
118 | $37 | $123 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
116 | $29 | $105 |
| Programming of single lead implantable defibrillator system Adjustment and testing of the settings for a single-lead implantable cardioverter-defibrillator (ICD) to ensure proper function. |
113 | $37 | $135 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
61 | $9 | $58 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
45 | $9 | $37 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
43 | $5 | $29 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
32 | $116 | $637 |
| Pacemaker system programming Adjustment and testing of a multi-lead pacemaker to ensure proper function and settings. |
21 | $42 | $145 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
14 | $365 | $1,812 |
| Insertion of implantable defibrillator system A surgical procedure to place an implantable cardioverter-defibrillator (ICD) device into the body. The device is connected to the heart to monitor heart rhythm and deliver shocks if dangerous arrhythmias occur. |
12 | $699 | $3,144 |
| Repair of left upper heart chamber with implant A surgical procedure to repair the left upper chamber of the heart using an implanted device, with review by a radiologist. |
11 | $379 | $2,342 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $64 | $161 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
78.9% high complexity
0.0% medium
21.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,136
Total received (2018-2024)
Avg $1,448/year across 7 years
Top 21% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
330
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,136 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$794
2023
$2,106
2022
$1,260
2021
$1,470
2020
$373
2019
$2,853
2018
$1,281
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$127
BIOTRONIK INC.
$127
Inari Medical, Inc.
$116
Biosense Webster, Inc.
$107
Novartis Pharmaceuticals Corporation
$61
Amgen Inc.
$47
Kiniksa Pharmaceuticals International, plc
$45
Lexicon Pharmaceuticals, Inc.
$41
PFIZER INC.
$36
E.R. Squibb & Sons, L.L.C.
$33
Abbott Laboratories
$21
Boston Scientific Corporation
$19
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 46.7% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$1,485
Janssen Pharmaceuticals, Inc
$944
Novartis Pharmaceuticals Corporation
$873
BIOTRONIK INC.
$734
Abbott Laboratories
$716
Amgen Inc.
$674
AstraZeneca Pharmaceuticals LP
$508
Boehringer Ingelheim Pharmaceuticals, Inc.
$410
Edwards Lifesciences Corporation
$368
Medtronic, Inc.
$350
Inari Medical, Inc.
$282
PFIZER INC.
$276
E.R. Squibb & Sons, L.L.C.
$243
Boston Scientific Corporation
$201
AngioDynamics, Inc.
$181
Philips Electronics North America Corporation
$159
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$137
Chiesi USA, Inc.
$135
Biosense Webster, Inc.
$129
HeartFlow, Inc.
$115
Impulse Dynamics (USA) Inc.
$97
Penumbra, Inc.
$94
Lexicon Pharmaceuticals, Inc.
$83
Alnylam Pharmaceuticals Inc.
$83
Gilead Sciences, Inc.
$72
Maquet Cardiovascular U.S. Sales, L.L.C.
$71
BOSTON SCIENTIFIC CORPORATION
$66
Astellas Pharma US Inc
$65
Relypsa, Inc.
$54
PORTOLA PHARMACEUTICALS, INC.
$48
Amarin Pharma Inc.
$47
Kiniksa Pharmaceuticals International, plc
$45
Merck Sharp & Dohme LLC
$45
Kiniksa Pharmaceuticals, Ltd.
$37
Novo Nordisk Inc
$36
Akcea Therapeutics, Inc.
$36
Bardy Diagnostics, Inc.
$35
ABIOMED
$27
Haemonetics Corporation
$24
Actelion Pharmaceuticals US, Inc.
$23
Otsuka America Pharmaceutical, Inc.
$22
Regeneron Healthcare Solutions, Inc.
$20
CSL Behring
$19
Merck Sharp & Dohme Corporation
$16
CHIESI USA, INC.
$13
SANOFI-AVENTIS U.S. LLC
$13
Medicure Pharma Inc.
$12
Shockwave Medical, Inc
$12
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
ANDEXXA · AZURE XT DR MRI SURESCAN · Acticor · Acticor 7 VR-T DX · Aggrastat (tirofiban HCl) · AngioVac · Arcalyst · Assurity Pacemaker · BEVYXXA · BRILINTA · BodyGuardian · CAMZYOS · CARDIOHELP · CHANTIX · CLEVIPREX · CLEVIPREX 50MG/100ML · Carnation Ambulatory Monitor · Corlanor · ELIQUIS · ENSITE · ENTRESTO · Ensite Cardiac Mapping System · FARXIGA · FFRct · FLOWTRIEVER CATHETER · GENERAL BRADY · GlideLight · IGT_D Therapy · INVOKANA · Impella · Indigo System · Inpefa · JARDIANCE · KENGREAL · Kcentra · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LifeVest · MINI TREK · Micra · NA · ONPATTRO · OPTIMIZER · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · PulseSelect · QDOT MICRO Catheter · Repatha · Reveal LINQ · S · SAMSCA · SYNERGY · TEG6S HEMOSTASIS SYSTEM · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · Veltassa · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIENCE V · Xience V coronary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
15
Per 100K population
7.6
County median income
$61,059
Nearest hospital
OUR LADY OF LOURDES MEMORIAL HOSPITAL, INC
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rehman is an electrophysiology & remote specialist, with above-average Medicare volume (top 30% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rehman experienced with remote pacemaker/defibrillator monitoring, 90 days?
Based on Medicare claims data, Dr. Rehman performed 820 remote pacemaker/defibrillator monitoring, 90 days services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rehman receive payments from pharmaceutical companies?
Yes. Dr. Rehman received a total of $10,136 from 48 companies across 330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rehman's costs compare to other cardiologists in Johnson City?
Dr. Rehman's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rehman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Johnson City
Browse cardiologists in Johnson City ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology